Listed by the USPTO as TRAN, SUSAN T
Tech Center 1600 • Art Units: 1615 1616 1618
This examiner grants 63% of resolved cases
TRAN, SUSAN T is assigned to Tech Center 1600 and Art Unit 1615. The profile records 1043 resolved cases, a 63.0% allowance rate, and a 34.8% interview lift. The median time to allowance is 1153 days. The substantial docket shows an allowance outcome above half of resolved cases, and the interview figure indicates that examiner discussions may have a significant role in advancing prosecution.
The listed companies are Shanghai Aucta Pharmaceuticals Co. Ltd., Sanotize Research And Development Corp., and Antecip Bioventures Ii LLC. The leading firms are FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, Fox Rothschild LLP, and PANITCH SCHWARZE BELISARIO & NADEL LLP. Counsel may benefit from early interview preparation supported by rigorous technical and written claim analysis.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17223756 | SPRAY DRIED NICOTINE FOR INCLUSION IN ORAL PRODUCTS | Non-Final OA | Altria Client Services LLC |
| 18815060 | ORAL PHARMACEUTICAL COMPOSITION | Non-Final OA | Otsuka Pharmaceutical Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy63.0% of resolved applications examined by Susan T Tran were allowed (1,043 resolved cases), compared with 43.4% across Art Unit 1615 over the last five years.
This examiner's interview lift is +34.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Susan T Tran took 1,153 days on average from filing to allowance.
Susan T Tran examines applications in Art Unit 1615 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
